Molecular and epigenetic modes of Fumonisin B1 mediated toxicity and carcinogenesis and detoxification strategies

被引:14
作者
Arumugam, Thilona [1 ]
Ghazi, Terisha [1 ]
Chuturgoon, Anil A. [1 ]
机构
[1] Univ KwaZulu Natal, Sch Lab Med & Med Sci, Discipline Med Biochem, Durban, South Africa
基金
新加坡国家研究基金会;
关键词
Fusarium; mycotoxins; fumonisin B-1; toxicity; oxidative stress; ER stress; immunotoxicity; epigenetics; mycotoxin detoxification; CERAMIDE SYNTHASE INHIBITION; OXIDATIVE STRESS; FUSARIUM-MONILIFORME; SPHINGOLIPID BIOSYNTHESIS; ENDOPLASMIC-RETICULUM; ESOPHAGEAL CANCER; DNA METHYLATION; AFLATOXIN B-1; MYCOTOXIN CONTAMINATION; INFLAMMATORY CYTOKINES;
D O I
10.1080/10408444.2021.1881040
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Fumonisin B-1 (FB1) is a natural contaminant of agricultural commodities that has displayed a myriad of toxicities in animals. Moreover, it is known to be a hepatorenal carcinogen in rodents and may be associated with oesophageal and hepatocellular carcinomas in humans. The most well elucidated mode of FB1-mediated toxicity is its disruption of sphingolipid metabolism; however, enhanced oxidative stress, endoplasmic reticulum stress, autophagy, and alterations in immune response may also play a role in its toxicity and carcinogenicity. Alterations to the host epigenome may impact on the toxic and carcinogenic response to FB1. Seeing that the contamination of FB1 in food poses a considerable risk to human and animal health, a great deal of research has focused on new methods to prevent and attenuate FB1-induced toxic consequences. The focus of the present review is on the molecular and epigenetic interactions of FB1 as well as recent research involving FB1 detoxification.
引用
收藏
页码:76 / 94
页数:19
相关论文
共 207 条
[61]   Panax ginseng extract modulates oxidative stress, DNA fragmentation and up-regulate gene expression in rats sub chronically treated with aflatoxin B1 and fumonisin B1 [J].
Hassan, Aziza M. ;
Abdel-Aziem, Sekena H. ;
El-Nekeety, Aziza A. ;
Abdel-Wahhab, Mosaad A. .
CYTOTECHNOLOGY, 2015, 67 (05) :861-871
[62]   Ceramide synthase inhibition by fumonisin B1 treatment activates sphingolipid-metabolizing systems in mouse liver [J].
He, Quanren ;
Suzuki, Hirofumi ;
Sharma, Neelesh ;
Sharma, Raghubir P. .
TOXICOLOGICAL SCIENCES, 2006, 94 (02) :388-397
[63]   In and out of the ER: Protein folding, quality control, degradation, and related human diseases [J].
Hebert, Daniel N. ;
Molinari, Maurizio .
PHYSIOLOGICAL REVIEWS, 2007, 87 (04) :1377-1408
[64]   Degradation of fumonisin B1 by the consecutive action of two bacterial enzymes [J].
Heinl, Stefan ;
Hartinger, Doris ;
Thamhesl, Michaela ;
Vekiru, Elisavet ;
Krska, Rudolf ;
Schatzmayr, Gerd ;
Moll, Wulf-Dieter ;
Grabherr, Reingard .
JOURNAL OF BIOTECHNOLOGY, 2010, 145 (02) :120-129
[65]   TOXICITY OF FUSARIUM-PROLIFERATUM-FERMENTED NIXTAMALIZED CORN-BASED DIETS FED TO RATS - EFFECT OF NUTRITIONAL-STATUS [J].
HENDRICH, S ;
MILLER, KA ;
WILSON, TM ;
MURPHY, PA .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 1993, 41 (10) :1649-1654
[66]  
Hendricks K, 1999, EPIDEMIOLOGY, V10, P198, DOI 10.1097/00001648-199903000-00022
[67]   Mechanisms of disease: Gene silencing in cancer in association with promoter hypermethylation [J].
Herman, JG ;
Baylin, SB .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (21) :2042-2054
[68]  
Howard P. C., 1999, MYCOTOXINS S, V1999, P45, DOI 10.2520/myco1975.1999.suppl2_45
[69]   Comparison of the toxicity of several fumonisin derivatives in a 28-day feeding study with female B6C3F1 mice [J].
Howard, PC ;
Couch, LH ;
Patton, RE ;
Eppley, RM ;
Doerge, DR ;
Churchwell, MI ;
Marques, MM ;
Okerberg, CV .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2002, 185 (03) :153-165
[70]   Compensatory regeneration as a mechanism for renal tubule carcinogenesis of fumonisin B1 in the F344/N/Nctr BR rat [J].
Howard, PC ;
Warbritton, A ;
Voss, KA ;
Lorentzen, RJ ;
Thurman, JD ;
Kovach, RM ;
Bucci, TJ .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2001, 109 :309-314